Follow
Zoltán Kis
Title
Cited by
Cited by
Year
Emerging technologies for low‐cost, rapid vaccine manufacture
Z Kis, R Shattock, N Shah, C Kontoravdi
Biotechnology journal 14 (1), 1800376, 2019
1442019
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
Z Kis, C Kontoravdi, R Shattock, N Shah
MDPI Vaccines 9 (1), 2020
1292020
Mammalian synthetic biology: emerging medical applications
Z Kis, HSA Pereira, T Homma, RM Pedrigi, R Krams
Journal of The Royal Society Interface 12 (106), 20141000, 2015
812015
Rapid development and deployment of high‐volume vaccines for pandemic response
Z Kis, C Kontoravdi, AK Dey, R Shattock, N Shah
Journal of advanced manufacturing and processing 2 (3), e10060, 2020
772020
Electricity generation technologies: Comparison of materials use, energy return on investment, jobs creation and CO2 emissions reduction
Z Kis, N Pandya, RHEM Koppelaar
Energy Policy 120, 144-157, 2018
652018
Quality by Design for enabling RNA platform production processes
S Daniel, Z Kis, C Kontoravdi, N Shah
Trends in Biotechnology 40 (10), 1213-1228, 2022
452022
Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases
NS Damien van de Berg, Zoltán Kis, Carl Fredrik Behmer, Karnyart Samnuan ...
npj Vaccines 6 (65), 1-10, 2021
42*2021
Optimization of lipid nanoparticles for saRNA expression and cellular activation using a design-of-experiment approach
HH Ly, S Daniel, SKV Soriano, Z Kis, AK Blakney
Molecular Pharmaceutics 19 (6), 1892-1905, 2022
302022
Stability modelling of mRNA vaccine quality based on temperature monitoring throughout the distribution chain
Z Kis
Pharmaceutics 14 (2), 430, 2022
292022
A model‐based quantification of the impact of new manufacturing technologies on developing country vaccine supply chain performance: A Kenyan case study
Z Kis, M Papathanasiou, R Calvo‐Serrano, C Kontoravdi, N Shah
Journal of Advanced Manufacturing and Processing 1 (3), e10025, 2019
262019
How to make enough vaccine for the world in one year
Z Kis, Z Rizvi
Public Citizen: Washington, DC, USA 37, 2021
252021
Comparative sustainability study of energy storage technologies using data envelopment analysis
F Rostami, Z Kis, R Koppelaar, L Jiménez, C Pozo
Energy Storage Materials 48, 412-438, 2022
222022
Pandemic-response adenoviral vector and RNA vaccine manufacturing
Z Kis, K Tak, D Ibrahim, MM Papathanasiou, B Chachuat, N Shah, ...
npj Vaccines 7 (1), 29, 2022
222022
Preclinical testing of an oncolytic parvovirus: standard protoparvovirus H-1PV efficiently induces osteosarcoma cell lysis in vitro
C Geiss, Z Kis, B Leuchs, M Frank-Stöhr, JR Schlehofer, J Rommelaere, ...
Viruses 9 (10), 301, 2017
212017
Computational investigations on the electronic structure and reactivity of thiourea dioxide: sulfoxylate formation, tautomerism and dioxygen liberation
Z Kis, SV Makarov, R Silaghi-Dumitrescu
Journal of Sulfur Chemistry 31 (1), 27-39, 2010
172010
Preclinical testing of an oncolytic parvovirus in Ewing sarcoma: protoparvovirus H-1 induces apoptosis and lytic infection in vitro but fails to improve survival in vivo
J Lacroix, Z Kis, R Josupeit, F Schlund, A Stroh-Dege, M Frank-Stöhr, ...
Viruses 10 (6), 302, 2018
152018
‘Super-reduced’iron under physiologically-relevant conditions
A Mot, K Zoltan, DA Svistunenko, G Damian, R Silaghi-Dumitrescu, ...
Dalton Transactions 39 (6), 1464-1466, 2010
132010
A new route to carbon monoxide adducts of heme proteins
SV Makarov, DS Salnikov, AS Pogorelova, Z Kis, R Silaghi-Dumitrescu
Journal of Porphyrins and Phthalocyanines 12 (10), 1096-1099, 2008
122008
GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
E Palmieri, Z Kis, J Ozanne, R Di Benedetto, B Ricchetti, L Massai, ...
Vaccines 10 (7), 1034, 2022
112022
Comparison between direct and reverse electroporation of cells in situ: a simulation study
L Towhidi, D Khodadadi, N Maimari, RM Pedrigi, H Ip, Z Kis, BR Kwak, ...
Physiological reports 4 (6), e12673, 2016
112016
The system can't perform the operation now. Try again later.
Articles 1–20